FDA — authorised 29 November 2007
- Application: NDA022048
- Marketing authorisation holder: HARROW EYE
- Status: approved
FDA authorised Triesence on 29 November 2007
Yes. FDA authorised it on 29 November 2007; FDA has authorised it.
HARROW EYE holds the US marketing authorisation.